AL
BCRX icon

Airain Ltd’s BioCryst Pharmaceuticals BCRX Stock Holding History

Airain Ltd’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-76,498
Closed -$1.14M – 848
2015
Q2 		$1.14M Buy
76,498
+64,747
+551% +$736K 0.06% 314
2015
Q1 		$106K Sell
11,751
-4,333
-27% -$44.9K 0.01% 759
2014
Q4 		$196K Buy
+16,084
New +$178K 0.02% 597
2014
Q3 		– Sell
-31,882
Closed -$406K – 796
2014
Q2 		$406K Sell
31,882
-30,424
-49% -$296K 0.03% 462
2014
Q1 		$659K Buy
62,306
+5,755
+10% +$61.4K 0.12% 288
2013
Q4 		$430K Buy
56,551
+27,308
+93% +$173K 0.06% 333
2013
Q3 		$213K Buy
+29,243
New +$148K 0.04% 390

Other funds holding BCRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Airain Ltd's BCRX Position: Q3 2015 in Review

Airain Ltd sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2015, closing a stake of 76,498 shares — an estimated $1.14M sold.

Airain Ltd first reported a position in BCRX in Q3 2013 and held it in 7 quarters. The position peaked at $1.14M in Q2 2015. 124 funds tracked by Wall St. Rank hold BCRX as of Q3 2015.

  • Airain Ltd reported no remaining BioCryst Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Airain Ltd sold 76,498 BioCryst Pharmaceuticals shares in Q3 2015, an estimated $1.14M.
  • Airain Ltd first reported a position in BioCryst Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Airain Ltd's BioCryst Pharmaceuticals position peaked at $1.14M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.